Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of AlirocumabEmil Hagström, Patricio López‐Jaramillo, Vera Bittner et al.|Circulation|2022Cited by 123
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMESPhilippe Gabríel Steg, Nikolaus Marx, Michael Szarek et al.|Circulation|2025Cited by 23